Orgenesis to Present at the 2017 Marcum MicroCap Conference
12 juin 2017 08h00 HE
|
Orgenesis Inc.
GERMANTOWN, MD--(Marketwired - Jun 12, 2017) - Orgenesis Inc. (OTCQB: ORGS), a vertically-integrated biopharmaceutical company with expertise and unique experience in cell therapy development and...
Orgenesis Provides Update Regarding AIP Cell-Based Therapy for Type 1 Diabetes, MaSTherCell Cell Manufacturing Subsidiary and Overall Financial Condition
08 mars 2017 09h00 HE
|
Orgenesis Inc.
GERMANTOWN, MD--(Marketwired - Mar 8, 2017) - Orgenesis Inc. (OTCQB: ORGS), a vertically-integrated biopharmaceutical company with expertise and unique experience in cell therapy development and...
Orgenesis Approved for Euro 12.3 Million European Grant for Further Development of Its Type 1 Diabetes Program
13 févr. 2017 08h30 HE
|
Orgenesis Inc.
GERMANTOWN, MD--(Marketwired - Feb 13, 2017) - Orgenesis Inc. (OTCQB: ORGS), a fully-integrated cell therapy and contract development and manufacturing company, announced that its Belgian...
Servier Appoints MaSTherCell for the Development of its CAR-T Cell Therapy Manufacturing Platform
20 janv. 2017 09h00 HE
|
Orgenesis Inc.
GERMANTOWN, MD--(Marketwired - Jan 20, 2017) - Orgenesis Inc. (OTCQB: ORGS), a fully-integrated cell therapy and contract development and manufacturing company, announced that its...
Orgenesis CEO Vered Caplan to Present at T1D Exchange Annual Meeting
20 oct. 2016 10h19 HE
|
Orgenesis Inc.
GERMANTOWN, MD--(Marketwired - Oct 20, 2016) - Orgenesis Inc. (OTCQB: ORGS), a fully integrated cell therapy and contract development and manufacturing company, announced that Orgenesis CEO, Vered...
Orgenesis CEO to Present at the 8th Annual Bioprocessing Summit
17 août 2016 09h00 HE
|
Orgenesis Inc.
GERMANTOWN, MD--(Marketwired - Aug 17, 2016) - Orgenesis Inc. (OTCQB: ORGS), a fully-integrated cell therapy and contract development and manufacturing company, announced that Orgenesis management...
Orgenesis and Atvio Biotech Launch Joint Venture for Gene and Cell Therapy Development Services
01 août 2016 09h00 HE
|
Orgenesis Inc.
GERMANTOWN, MD--(Marketwired - Aug 1, 2016) - Orgenesis Inc. (OTCQB: ORGS), a fully integrated cell therapy and contract development and manufacturing company (the "Company" or "Orgenesis") has...
Orgenesis and CureCell Awarded Grant From the KORIL Fund for Diabetes Research and Development
07 juin 2016 09h00 HE
|
Orgenesis Inc.
GERMANTOWN, MD--(Marketwired - Jun 7, 2016) - Orgenesis Ltd., a wholly-owned subsidiary of Orgenesis Inc. (OTCQB: ORGS), a fully integrated cell therapy and regenerative medicine company with a...
Orgenesis and Pall Corporation Receive $800,000 Grant From BIRD Foundation for Diabetes Research and Development
26 janv. 2015 08h48 HE
|
Orgenesis Inc.
TEL AVIV, ISRAEL--(Marketwired - Jan 26, 2015) - Orgenesis Ltd., a wholly-owned subsidiary of Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and regenerative...
Orgenesis Receives Patent for Potential Cure for Type 1 Diabetes
15 oct. 2014 07h00 HE
|
Orgenesis Inc.
GERMANTOWN, MD--(Marketwired - Oct 15, 2014) - Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and regenerative medicine, today announced that it has received a...